A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy.
Peebles
R Stokes
RS
Moore
Martin L
ML
D000368:Aged; D000402:Airway Obstruction / Q000188:drug therapy; D000818:Animals; D000914:Antibodies, Viral / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002417:Cattle; D006801:Humans; D007223:Infant; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D051379:Mice; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy*; D012136:Respiratory Syncytial Viruses / Q000472:pathogenicity*
D000914:Antibodies, Viral; D000998:Antiviral Agents; D007555:Isoxazoles; D000077339:Leflunomide